Clinical Trial Update: Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating serplulimab in combination with chemotherapy as neoadjuvant therapy for locally advanced gastric cancer and adenocarc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagogastric Junction
• Gastric Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Xijing Hospital | Conditions: Stomach Neoplasms, Immune Checkpoint Inhibitors | Phase 2 | Status: RECRUITING